Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients

PHASE3CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Acute PainFever
Interventions
DRUG

IV Acetaminophen

Arm 1: 1 g IV Acetaminophen every 6 hours administered for five days. Arm 2: 650 mg IV Acetaminophen every 4 hours administered for five days. Arm 3: The standard of care treatments were defined as any medication the investigator deemed appropriate to treat the subject, including products containing acetaminophen but excluding IV acetaminophen.

Trial Locations (14)

10021

Weill Medical College of Cornell University, New York

19107

Thomas Jefferson University, Philadelphia

33136

University of Miami School of Medicine, Miami

34429

Nature Coast Clinical Research, Crystal River

34950

G&G Research, Ft. Pierce

43210

The Ohio State University Medical Center, Columbus

77024

Memorial Herman/Memorial City Hospital, Houston

91007

Arcadia Methodist Hospital, Arcadia

91105

Huntington Memorial Hospital, Pasadena

Lotus Clinical Research, Inc., Pasadena

91206

Glendale Adventist Medical Center, Glendale

92653

Accurate Clinical Trials, Inc., Laguna Hills

93105

Santa Barbara Cottage Hospital, Santa Barbara

97239

Oregon Health Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY